The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Neuroinflammation in Bipolar Depression
Open accessAbstract
Bipolar disorder (BD) is a leading cause of worldwide disability among mood disorders. Pathological mechanisms are still vastly unclear, and current treatments with conventional medications are often unsatisfactory in maintaining symptoms control and an adequate quality of life. Consequently, current research is focusing on shedding new light on disease pathogenesis, to improve therapeutic effectiveness. Recent evidence has suggested a prominent role of inflammation in mood disorders. Elevated levels of peripheral proinflammatory mediators have been reported in BD, as well as in other mood disorders, and people with systemic autoimmune diseases have an increased risk of developing BD. These immunological alterations are stable, and current medications are unable to alter peripheral concentrations even when clinical improvement is evident. These findings have also been replicated in the central nervous system (CNS) milieu, whereas genetic studies have shown that these immune alterations are not due to the disorder itself, being detectable before the illness onset. Moreover, these inflammatory modifications seem to be affected by and linked to other biomarkers of the disorder, such as alterations of white matter (WM) microstructure, metabolism, kynurenine pathway, and circadian rhythmicity. Finally, these immune variations seem to be useful as predictors of therapeutic responsiveness to medications, and in discriminating between clinically different outcomes. The objective of this review is to summarize available evidence on the connection between inflammation and BD, focusing on peripheral inflammatory markers and recent findings on their connection with other typical features of BD, to outline a general overview of the disorder. Moreover, it is meant to analyze the issues with data gathering and interpretation, given the partially contradictory and inconsistent nature of results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Subgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Neuroinflammation and M2 Microglia: The Good, the Bad, and the Inflamed
Cherry, J. D., Olschowka, J. A., & O’Banion, M. K. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-98 · Cited by 1,748
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
Immune modulation of learning, memory, neural plasticity and neurogenesis
Yirmiya, R., & Goshen, I. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.015 · Cited by 1,483
Oligodendrocytes: biology and pathology
Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0601-5 · Cited by 933
TNF-α in promotion and progression of cancer
Balkwill, F. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9005-3 · Cited by 915
Hannestad, J., DellaGioia, N., & Bloch, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.132 · Cited by 914
Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001805 · Cited by 794
Neural circuits underlying the pathophysiology of mood disorders
Price, J. L., & Drevets, W. C. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.12.011 · Cited by 788
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
Maes, M., Bosmans, E., De Jongh, R., Kenis, G., Vandoolaeghe, E., & Neels, H. (1997) · Cytokine · doi:10.1006/cyto.1997.0238 · Cited by 728
Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission
Pascual, O., Ben Achour, S., Rostaing, P., Triller, A., & Bessis, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111098109 · Cited by 693
Uranova, N. A., Vostrikov, V. M., Orlovskaya, D. D., & Rachmanova, V. I. (2004) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00181-6 · Cited by 659
Phillips, M. L., & Swartz, H. A. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13081008 · Cited by 636
Wise, T., Radua, J., Via, E., Cardoner, N., Abe, O., Adams, T. M., Amico, F., Cheng, Y., Cole, J. H., de Azevedo Marques Périco, C., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.72 · Cited by 606
A brief history of the development of antidepressant drugs: From monoamines to glutamate.
Hillhouse, T. M., & Porter, J. H. (2015) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0038550 · Cited by 605
Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation
Harvey, A. G. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08010098 · Cited by 601
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Ashok, A. H., Marques, T. R., Jauhar, S., Nour, M. M., Goodwin, G. M., Young, A. H., & Howes, O. D. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.16 · Cited by 546
Kynurenine pathway in major depression: Evidence of impaired neuroprotection
Myint, A.-M., Kim, Y. K., Verkerk, R., Scharpé, S., Steinbusch, H., & Leonard, B. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.07.013 · Cited by 527
How might circadian rhythms control mood? Let me count the ways
McClung, C. A. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.02.019 · Cited by 507
Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder
Brietzke, E., Stertz, L., Fernandes, B. S., Kauer-Sant’Anna, M., Mascarenhas, M., Escosteguy Vargas, A., Chies, J. A., & Kapczinski, F. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.12.001 · Cited by 423
Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis
Munkholm, K., Braüner, J. V., Kessing, L. V., & Vinberg, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.018 · Cited by 402
The kynurenine system and immunoregulation
Mándi, Y., & Vécsei, L. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-011-0681-y · Cited by 401
Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder
Kim, Y.-K., Jung, H.-G., Myint, A.-M., Kim, H., & Park, S.-H. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.02.018 · Cited by 375
Alesci, S., Martinez, P. E., Kelkar, S., Ilias, I., Ronsaville, D. S., Listwak, S. J., Ayala, A. R., Licinio, J., Gold, H. K., Kling, M. A., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1667 · Cited by 372
Factors regulating microglia activation
Kierdorf, K., & Prinz, M. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00044 · Cited by 360
Schwartz, M., & Baruch, K. (2014) · The EMBO Journal · doi:10.1002/embj.201386609 · Cited by 349
Neuroplasticity and cellular resilience in mood disorders
Manji, H. K., Moore, G. J., Rajkowska, G., & Chen, G. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000811 · Cited by 340
Abbasi, S.-H., Hosseini, F., Modabbernia, A., Ashrafi, M., & Akhondzadeh, S. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.03.033 · Cited by 339
Padmos, R. C., Hillegers, M. H. J., Knijff, E. M., Vonk, R., Bouvy, A., Staal, F. J. T., de Ridder, D., Kupka, R. W., Nolen, W. A., & Drexhage, H. A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.395 · Cited by 336
Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder
Eller, T., Vasar, V., Shlik, J., & Maron, E. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.015 · Cited by 290
Cytokine profiles in bipolar affective disorder: focus on acutely ill patients.
O'Brien, S. M., Scully, P., Scott, L. V., & Dinan, T. G. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.11.015 · Cited by 285
Rosenblat, J., & McIntyre, R. (2017) · Brain Sciences · doi:10.3390/brainsci7110144 · Cited by 258
Immune variations in bipolar disorder: phasic differences
Ortiz‐Domínguez, A., Hernández, M. E., Berlanga, C., Gutiérrez‐Mora, D., Moreno, J., Heinze, G., & Pavón, L. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00493.x · Cited by 255
The kynurenine pathway in schizophrenia and bipolar disorder
Erhardt, S., Schwieler, L., Imbeault, S., & Engberg, G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.05.020 · Cited by 255
Fernandes, B. S., Steiner, J., Molendijk, M. L., Dodd, S., Nardin, P., Gonçalves, C.-A., Jacka, F., Köhler, C. A., Karmakar, C., Carvalho, A. F., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30370-4 · Cited by 247
Melatonin Suppression by Light in Euthymic Bipolar and Unipolar Patients
Nurnberger, J. I. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.6.572 · Cited by 241
Benedetti, F., Yeh, P.-H., Bellani, M., Radaelli, D., Nicoletti, M. A., Poletti, S., Falini, A., Dallaspezia, S., Colombo, C., Scotti, G., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.028 · Cited by 229
Self-citationHigher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression
Yoshimura, R., Hori, H., Ikenouchi-Sugita, A., Umene-Nakano, W., Ueda, N., & Nakamura, J. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.03.020 · Cited by 227
Neuroinflammation in bipolar disorder – A [11C]-(R)-PK11195 positron emission tomography study
Haarman, B. C. M. (., Riemersma-Van der Lek, R. F., de Groot, J. C., Ruhé, H. G. (., Klein, H. C., Zandstra, T. E., Burger, H., Schoevers, R. A., de Vries, E. F. J., Drexhage, H. A., et al. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.03.016 · Cited by 211
Cell pathology in bipolar disorder
Rajkowska, G. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01149.x · Cited by 201
What is the tryptophan kynurenine pathway and why is it important to neurotherapeutics?
Davis, I., & Liu, A. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1049999 · Cited by 200
Kunz, M., Ceresér, K. M., Goi, P. D., Fries, G. R., Teixeira, A. L., Fernandes, B. S., Belmonte-de-Abreu, P. S., Kauer-Sant'Anna, M., Kapczinski, F., & Gama, C. S. (2011) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462011000300010 · Cited by 190
Patel, J. P., & Frey, B. N. (2015) · Neural Plasticity · doi:10.1155/2015/708306 · Cited by 177
Zhang, Y., Catts, V. S., Sheedy, D., McCrossin, T., Kril, J. J., & Shannon Weickert, C. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.238 · Cited by 174
The activation of monocyte and T cell networks in patients with bipolar disorder
Drexhage, R. C., Hoogenboezem, T. H., Versnel, M. A., Berghout, A., Nolen, W. A., & Drexhage, H. A. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.03.013 · Cited by 173
Opposite effects of suicidality and lithium on gray matter volumes in bipolar depression
Benedetti, F., Radaelli, D., Poletti, S., Locatelli, C., Falini, A., Colombo, C., & Smeraldi, E. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.07.006 · Cited by 165
Self-citationThe underlying neurobiology of bipolar disorder.
Manji, H. K., Quiroz, J. A., Payne, J. L., Singh, J., Lopes, B. P., Viegas, J. S., & Zarate, C. A. (2003) · Europe PMC (PubMed Central) · Cited by 165
Mood Disorders and Obesity: Understanding Inflammation as a Pathophysiological Nexus
Soczynska, J. K., Kennedy, S. H., Woldeyohannes, H. O., Liauw, S. S., Alsuwaidan, M., Yim, C. Y., & McIntyre, R. S. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8140-8 · Cited by 164
Number and Function of Circulating Human Antigen Presenting Cells Regulated by Sleep
Dimitrov, S., Lange, T., Nohroudi, K., & Born, J. (2007) · Sleep · doi:10.1093/sleep/30.4.401 · Cited by 164
Lesh, T. A., Careaga, M., Rose, D. R., McAllister, A. K., de Water, J. V., Carter, C. S., & Ashwood, P. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1197-2 · Cited by 164
Deficiencies of the T and natural killer cell system in major depressive disorder
Grosse, L., Hoogenboezem, T., Ambrée, O., Bellingrath, S., Jörgens, S., de Wit, H. J., Wijkhuijs, A. M., Arolt, V., & Drexhage, H. A. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.12.003 · Cited by 163
Insulin resistance and outcome in bipolar disorder
Calkin, C. V., Ruzickova, M., Uher, R., Hajek, T., Slaney, C. M., Garnham, J. S., O'Donovan, M. C., & Alda, M. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.152850 · Cited by 158
C-Reactive Protein Alterations in Bipolar Disorder: A Meta-Analysis
Dargél, A. A., Godin, O., Kapczinski, F., Kupfer, D. J., & Leboyer, M. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14r09007 · Cited by 155
Inflammatory cytokines influence measures of white matter integrity in Bipolar Disorder
Benedetti, F., Poletti, S., Hoogenboezem, T. A., Mazza, E., Ambrée, O., de Wit, H., Wijkhuijs, A. J. M., Locatelli, C., Bollettini, I., Colombo, C., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.05.047 · Cited by 151
Self-citationKonradi, C. L., Daws, S. E., & Clay, H. B. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.025 · Cited by 149
Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder
Brietzke, E. M., Kauer‐Sant’Anna, M., Teixeira, A. L., & Kapczinski, F. P. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.04.008 · Cited by 143
Bai, Y., Su, T., Li, C., Tsai, S., Chen, M., Tu, P., & Chiou, W.-F. (2014) · Bipolar Disorders · doi:10.1111/bdi.12259 · Cited by 142
Fagiolini, A. M., Chengappa, K. N. R., Soreca, I., & Chang, J. P. (2008) · CNS Drugs · doi:10.2165/00023210-200822080-00004 · Cited by 138
Morris, G., Stubbs, B., Köhler, C. A., Walder, K. R., Slyepchenko, A., Berk, M., & Carvalho, A. F. (2018) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2018.03.007 · Cited by 135
Sluzewska, A., Sobieska, M., & Rybakowski, J. K. (2008) · Neuropsychobiology · doi:10.1159/000119332 · Cited by 134
Bai, Y., Su, T., Tsai, S., Chiou, W., Li, C., Tu, P., & Mu-Hong, C. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.05.009 · Cited by 131
Serotonin and bipolar disorder
Mahmood, T., & Silverstone, T. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00226-3 · Cited by 126
Decreased Serum Level of miR-146a as Sign of Chronic Inflammation in Type 2 Diabetic Patients
Baldeón, L., Weigelt, K., de Wit, H., Özcan, B., van Oudenaren, A., Sempértegui, F., Sijbrands, E. J. G., Grosse, L., Freire, W. B., Drexhage, H. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115209 · Cited by 124
COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
Müller, N. (2010) · PubMed · Cited by 122
The Differential Levels of Inflammatory Cytokines and BDNF among Bipolar Spectrum Disorders
Wang, T., Lee, S.-Y., Chen, S., Chung, Y.-L., Li, C., Chang, Y., Wang, L., Chen, P. S., Chen, S., Chu, C., et al. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw012 · Cited by 122
Melatonin, clock genes and mitochondria in sepsis
Acuña-Castroviejo, D., Rahim, I., Acuña‐Fernández, C., Fernández‐Ortiz, M., Marín, J. S., Sayed, R. K. A., Díaz-Casado, M. E., Rusanova, I., López, L. C., & Escames, G. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2610-1 · Cited by 119
Immunologic variables in acute mania of bipolar disorder
Liu, H., Yang, Y., Chou, Y.-M., Chen, K.-P., Shen, W. W., & Leu, S. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.01.006 · Cited by 118
The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications
Felger, J. C. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_13 · Cited by 115
Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder.
Barbosa, I. G., Huguet, R. B., Mendonça, V. A., Sousa, L. P., Neves, F. S., Bauer, M. E., & Teixeira, A. L. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0116-z · Cited by 108
Chemokines in bipolar disorder: Trait or state?
Barbosa, I. G., Rocha, N. P., Bauer, M. E., de Miranda, A. S., Huguet, R. B., Reis, H. J., Zunszain, P. A., Horowitz, M. A., Pariante, C. M., & Teixeira, A. L. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0327-6 · Cited by 103
Serum Leptin and Cholesterol Levels in Patients with Bipolar Disorder
Atmaca, M., Kuloğlu, M., Tezcan, E., Üstündağ, B., & Bayik, Y. (2002) · Neuropsychobiology · doi:10.1159/000067809 · Cited by 99
Haarman, B. C. M., Burger, H., Doorduin, J., Renken, R. J., Sibeijn‐Kuiper, A., Marsman, J.-B. C., de Vries, E. F. J., de Groot, J. C., Drexhage, H. A., Mendes, R., et al. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.09.004 · Cited by 89
A brief review of exercise, bipolar disorder, and mechanistic pathways
Thomson, D., Turner, A., Lauder, S., Gigler, M. E., Berk, L., Singh, A., Pasco, J. A., Berk, M., & Sylvia, L. G. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.00147 · Cited by 85
Increased levels of adipokines in bipolar disorder
Barbosa, I. G., Rocha, N. P., de Miranda, A. S., Magalhães, P. V. D. S., Huguet, R. B., de Souza, L. P., Kapczinski, F. P., & Teixeira, A. L. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.11.010 · Cited by 85
Schwartz, M., & Baruch, K. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.08.002 · Cited by 85
Jacoby, A. S., Munkholm, K., Vinberg, M., Pedersen, B. K., & Kessing, L. V. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.03.040 · Cited by 84
Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder
Birner, A., Platzer, M., Bengesser, S., Dalkner, N., Fellendorf, F. T., Queissner, R., Pilz, R., Rauch, P., Maget, A., Hamm, C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172699 · Cited by 84
Poletti, S., de Wit, H., Mazza, E. B., Wijkhuijs, A. J. M., Locatelli, C., Aggio, V., Colombo, C., Benedetti, F., & Drexhage, H. A. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.12.020 · Cited by 82
Self-citationBenedetti, F., Lucca, A., Brambilla, F., Colombo, C., & Smeraldi, E. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00255-5 · Cited by 81
Self-citationLack of behavioral effects of monoamine depletion in healthy subjects.
Salomon, R., Miller, H. L., Krystal, J., Heninger, G., & Charney, D. (1997) · Biological Psychiatry · doi:10.1016/0006-3223(95)00670-2 · Cited by 80
Pezzoli, S., Emsell, L., Yip, S. W., Dima, D., Giannakopoulos, P., Zarei, M., Tognin, S., Arnone, D., James, A. C., Haller, S., et al. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.11.005 · Cited by 80
Hung, Y., Hsieh, C., Chen, Y., Pei, D., Kuo, S., Shen, D., Sheu, W. H., & Chen, Y. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02963.x · Cited by 78
Bellani, M., Boschello, F., Delvecchio, G., Dusi, N., Altamura, C. A., Ruggeri, M., & Brambilla, P. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00021 · Cited by 75
Eker, M. C., Şimşek, F., Yılmazer, E. E., Kitiş, Ö., ÇINAR, C., Eker, Ö. D., Coburn, K. L., & Gönül, A. S. (2014) · Bipolar Disorders · doi:10.1111/bdi.12181 · Cited by 74
Higher Baseline Proinflammatory Cytokines Mark Poor Antidepressant Response in Bipolar Disorder
Benedetti, F., Poletti, S., Hoogenboezem, T. A., Locatelli, C., de Wit, H., Wijkhuijs, A. J. M., Colombo, C., & Drexhage, H. A. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16m11310 · Cited by 74
Self-citationMao, R., Zhang, C., Chen, J., Zhao, G., Zhou, R., Wang, F., Xu, J., Yang, T., Su, Y., Huang, J., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.115 · Cited by 68
Assessment of cytokine levels and hs-CRP in bipolar I disorder before and after treatment
Uyanik, V., Tuğlu, C., Görgülü, Y., Kunduracılar, H., & Uyanık, M. Ş. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.05.078 · Cited by 67
Weight Gain and Serum Leptin Levels in Patients on Lithium Treatment
Atmaca, M., Kuloğlu, M., Tezcan, E., & Üstündağ, B. (2002) · Neuropsychobiology · doi:10.1159/000065414 · Cited by 65
Genetic and Environmental Influences on Pro-Inflammatory Monocytes in Bipolar Disorder: A Twin Study
Padmos, R. C., van Baal, G. C. M., Vonk, R., Wijkhuijs, A. J. M., Kahn, R. S., Nolen, W. A., & Drexhage, H. A. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.116 · Cited by 64
The yin/yang of inflammatory status: Blood-brain barrier regulation during sleep
Hurtado‐Alvarado, G., Becerril‐Villanueva, E., de Oca, A. C.-M., Domı́nguez-Salazar, E., Salinas-Jazmín, N., Pérez‐Tapia, S. M., Pavón, L., Velázquez‐Moctezuma, J., & Gómez‐González, B. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.11.009 · Cited by 64
C-Reactive Protein: A Differential Biomarker For Major Depressive Disorder and Bipolar II Disorder
Chang, H. H., Wang, T.-Y., Lee, I. H., Lee, S.-Y., Chen, K. C., Huang, S.-Y., Yang, Y. K., Lu, R.-B., & Chen, P. S. (2017) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2016.1155746 · Cited by 61
Chronobiology of Bipolar Disorder: Therapeutic Implication
Dallaspezia, S., & Benedetti, F. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0606-9 · Cited by 59
Self-citationElmslie, J. L., Porter, R., Joyce, P. R., Hunt, P. J., Shand, B. I., & Scott, R. S. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670802534341 · Cited by 59
Structure–function associations in hippocampus in bipolar disorder
Chepenik, L. G., Wang, F., Spencer, L., Spann, M., Kalmar, J. H., Womer, F., Kale Edmiston, E., Pittman, B., & Blumberg, H. P. (2012) · Biological Psychology · doi:10.1016/j.biopsycho.2012.01.008 · Cited by 56
Bipolar Disorder: The Role of the Kynurenine and Melatonergic Pathways.
Anderson, G., Jacob, A., Bellivier, F., & Geoffroy, P. (2016) · Current pharmaceutical design · doi:10.2174/1381612822666151214105314 · Cited by 55
Magioncalda, P., Martino, M., Tardito, S., Sterlini, B., Conio, B., Marozzi, V., Adavastro, G., Capobianco, L., Russo, D., Parodi, A., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.04.017 · Cited by 53
Recent Findings on the Role of White Matter Pathology in Bipolar Disorder
Benedetti, F., & Bollettini, I. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000007 · Cited by 52
Self-citationKynurenine pathway and white matter microstructure in bipolar disorder
Poletti, S., Myint, A.-M., Schütze, G. A., Bollettini, I., Mazza, E. B., Grillitsch, D., Locatelli, C., Schwarz, M., Colombo, C., & Benedetti, F. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0731-4 · Cited by 52
Self-citationExercise-induced release of cytokines in patients with major depressive disorder
Hallberg, L., Janelidze, S., Engström, G., Wisén, A. G. M., Westrin, Å., & Brundin, L. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.02.133 · Cited by 51
Interleukin-1β is associated with depressive episode in major depression but not in bipolar disorder
Mota, R., Gazal, M., Acosta, B. A., de Leon, P. B., Jansen, K., Pinheiro, R. T., Souza, L. D. D. M., Silva, R. A., Oses, J. P., Quevedo, L. D. Á., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.08.020 · Cited by 50
Chatzigeorgiou, A., & Chavakis, T. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_8 · Cited by 48
Chen, M., Chang, W.-C., Hsu, J.-W., Huang, K., Tu, P., Su, T., Li, C., Lin, W.-C., & Bai, Y. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.10.106 · Cited by 47
Towards an integrative picture of human sickness behavior
Shattuck, E. C., & Muehlenbein, M. P. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.05.002 · Cited by 46
Stem Cell Factor (SCF) is a putative biomarker of antidepressant response
Benedetti, F., Poletti, S., Hoogenboezem, T. A., Locatelli, C., Ambrée, O., de Wit, H., Wijkhuijs, A. J. M., Mazza, E. B., Bulgarelli, C., Vai, B., et al. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9672-y · Cited by 45
Self-citationKieseppä, T., Mäntylä, R., Tuulio‐Henriksson, A., Luoma, K., Mantere, O., Ketokivi, M. A., Holma, M., Jylhä, P. J., Melartin, T. K., Suominen, K. H., et al. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2013.08.002 · Cited by 44
Duarte, J. Á., Silva, J. Q. D. A. E., Goldani, A. A. S., Massuda, R., & Gama, C. S. (2016) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2015-1793 · Cited by 44
Body mass index associates with white matter microstructure in bipolar depression
Mazza, E. B., Poletti, S., Bollettini, I., Locatelli, C., Falini, A., Colombo, C., & Benedetti, F. (2017) · Bipolar Disorders · doi:10.1111/bdi.12484 · Cited by 44
Self-citationDisruption of white matter integrity marks poor antidepressant response in bipolar disorder
Bollettini, I., Poletti, S., Locatelli, C., Vai, B., Smeraldi, E., Colombo, C., & Benedetti, F. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.010 · Cited by 43
Self-citationThe role of obesity measures in the development and persistence of major depressive disorder
Gibson-Smith, D., Bot, M., Paans, N. P. G., Visser, M., Brouwer, I. A., & Penninx, B. W. J. H. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.03.032 · Cited by 43
Wang, L.-Y., Chen, S., Chiang, J., Hsu, C. Y., & Shen, Y. (2018) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-018-1622-y · Cited by 37
Glial Abnormalities in Mood Disorders
Öngür, D., Bechtholt, A. J., Carlezon, W. A., & Cohen, B. M. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000060 · Cited by 34
White matter hyperintensities in young individuals with bipolar disorder or at high genetic risk
Wadhwa, R., Wen, W. X., Frankland, A., Leung, V., Sinbandhit, C., Stuart, A., Dawes, L. C., Hadzi-Pavlovic, D., Lévy, F., Lenrootl, R., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.10.368 · Cited by 21
Dysregulation of cytokine coding genes in peripheral blood of bipolar patients
Ghafouri‐Fard, S., Oskooei, V. K., Omrani, M. D., & Taheri, M. N. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.06.028 · Cited by 20
Dong, D., Wang, Y., Chang, X., Chen, X., Chang, X., Luo, C., & Yao, D. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.07.003 · Cited by 18
Bipolar Disorder Associated with Another Autoimmune Disease—Pemphigus: A Population-based Study
Kridin, K., Zelber‐Sagi, S., Comaneshter, D. S., & Cohen, A. D. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743717740344 · Cited by 18
Mitochondrial Impairment in Oligodendroglial Cells Induces Cytokine Expression and Signaling
Scheld, M., Fragoulis, A., Nyamoya, S., Zendedel, A., Denecke, B., Krauspe, B., Teske, N., Kipp, M., Beyer, C., & Clarner, T. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1236-6 · Cited by 17
The role of IL-6 and STAT in sleep and neuroinflammation
Fernandes, G. L., Araujo, P., Tufik, S. B., & Andersen, M. L. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.04.004 · Cited by 16
Tsai, S., Lee, H., & Chen, C. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.03.003 · Cited by 13
Cited by
Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors
Mazza, M. G., De Lorenzo, R., Conte, C., Poletti, S., Vai, B., Bollettini, I., Melloni, E. M. T., Furlan, R., Ciceri, F., Rovere-Querini, P., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.07.037 · Cited by 1,804
Self-citationWang, Q., Xu, R., & Volkow, N. D. (2021) · World Psychiatry · doi:10.1002/wps.20806 · Cited by 617
Mazza, M. G., Palladini, M., De Lorenzo, R., Magnaghi, C., Poletti, S., Furlan, R., Ciceri, F., Rovere-Querini, P., & Benedetti, F. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.02.021 · Cited by 513
Self-citationDopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 308
Role of Oxidative Stress and Neuroinflammation in Attention-Deficit/Hyperactivity Disorder
Corona, J. C. (2020) · Antioxidants · doi:10.3390/antiox9111039 · Cited by 163
Metadata
- Authors
- Benedetti, F., Aggio, V., Pratesi, M. L., Greco, G., & Furlan, R.
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2020-02-26
- Volume
- 11
- Pages
- 71-71
- ISSN
- 1664-0640 (ISSN-L)
- OpenAlex
- W3007637026
- Cited by
- 274
- References
- 126
- FWCI
- 26.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.